ApicHope Pharmaceutical Group Co., Ltd. (SHE:300723)

China flag China · Delayed Price · Currency is CNY
38.71
+0.42 (1.10%)
Apr 28, 2026, 3:12 PM CST
Market Cap17.38B +50.5%
Revenue (ttm)940.78M -21.9%
Net Income199.99M
EPS0.44
Shares Out449.03M
PE Ratio87.44
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume29,278,139
Average Volume20,320,490
Open35.17
Previous Close38.29
Day's Range35.17 - 40.21
52-Week Range29.31 - 81.48
Beta0.53
RSI63.63
Earnings DateApr 24, 2026

About SHE:300723

ApicHope Pharmaceutical Group Co., Ltd. engages in the research, development, production, and sale of pharmaceutical drugs in China. The company offers pediatric medicines, such as fuganlin and yiqi jianpi oral liquids, carboxymestrine oral solutions, and xiao’er kechuanling oral liquid products; and clindamycin palmitate hydrochloride dispersible tablets, acetylkitasamycin for suspension, qinxiangqingjie oral liquids, epinastine hydrochloride granules, clindamycin palmitate hydrochloride granules, clindamyxin hydrochloride for injection, clind... [Read more]

Sector Healthcare
Founded 2002
Employees 1,484
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300723
Full Company Profile

Financial Performance

In 2025, SHE:300723's revenue was 932.27 million, a decrease of -35.72% compared to the previous year's 1.45 billion. Losses were -337.79 million, -37.45% less than in 2024.

Financial Statements